Follow
Rare Cancer
Rare cancers are characterized by the National Institute of Health as those malignancies which inflect less than 40,000 people annually in the United States. Combined, all rare cancers account for about 25% of all cancer diagnoses. Unfortunately, research and development of new therapies for rare cancers is challenging, resulting in slow progress for new therapeutic approaches. While rare cancers exist in many organs throughout the body, all childhood cancers are considered rare.
JUL 02, 2020 | 12:45 PM
Most bladder cancer (BC) cases are non-muscle-invasive BC (NIBMC), which is rarely lethal. However, nearly one-fifth of NMIBC cases progress to muscle-invasive BC (MIBC), which shows a 5-yea...
JUN 26, 2020 | 8:00 AM
DATE: June 26, 2020 TIME: 8:00am PT Structural variants (SVs) are an important source of genetic variation in the human genome and they are involved in a multitude of human diseases as well...
JUN 18, 2020 | 9:00 AM
DATE: June 18, 2020 TIME: 9:00am PDT, 12:00pm EDT Despite the success of immunotherapy against several malignancies including melanoma and lung adenocarcinoma, glioblastoma remains the excep...
JUN 03, 2020 | 12:00 AM
The mammary gland is a unique organ that develops predominantly after birth and undergoes dramatic remodelling in reproductive phases. Macrophages have been implicated in mammary gland funct...
MAY 20, 2020 | 7:30 AM
Precision medicine is the paradigm to develop treatments for patients based on molecular-targets that are effective in vivo when administered. In addition to identifying the molecular and ce...
APR 24, 2020 | 8:00 AM
The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory tes...
APR 22, 2020 | 8:00 AM
C.E. CREDITS
Discover strategies for labs to optimize coagulation testing, improve patient outcomes, and strengthen their role in clinical care teams....
APR 22, 2020 | 12:00 AM
Achieving a diagnosis in rare disease patients can be challenging for even the most experienced clinician or scientist, creating a barrier to delivering truly personalised care. An exome seq...
APR 20, 2020 | 8:00 AM
C.E. CREDITS
Explore emergency hemostasis testing approaches, from rapid lab assays to viscoelastic methods, for managing bleeding patients....
